Table 1.
Baseline clinical characteristics of the study population.
| Group | p-Value | ||
|---|---|---|---|
| Younger (≤60 y.o.) 92 (24.1%) |
Older (>60 y.o.) 289 (75.9%) |
||
| Gender, female, n (%) | 15 (16.3) | 77 (26.6) | 0.044 |
| Height, cm, median (Q1–Q3) | 172.0 (168.0–177.0) | 170.0 (165.0–176.0) | 0.030 |
| Weight, kg, median (Q1–Q3) | 88.0 (76.0–98.0) | 84.0 (73.0–92.0) | 0.027 |
| BMI, kg/m2, median (Q1–Q3) | 29.1 (26.2–32.3) | 28.4 (25.3–31.5) | 0.23 |
| Diabetes mellitus, n (%) | 27 (29.4) | 127 (43.9) | 0.013 |
| Arterial hypertension, n (%) | 73 (79.4) | 258 (89.6) | 0.011 |
| Atrial fibrillation, n (%) | 8 (8.7) | 67 (23.3) | 0.002 |
| Previous MI, n (%) | 42 (45.7) | 136 (47.1) | 0.81 |
| Previous PCI, n (%) | 40 (43.5) | 156 (54.0) | 0.08 |
| Previous CABG, n (%) | 1 (1.1) | 13 (4.51) | 0.20 |
| PAD, n (%) | 5 (5.4) | 48 (16.7) | 0.007 |
| Current smoker, n (%) | 55 (59.8) | 135 (46.7) | 0.029 |
| COPD, n (%) | 4 (4.4) | 23 (8.0) | 0.24 |
| Previous stroke/TIA, n (%) | 5 (5.4) | 30 (10.4) | 0.15 |
| Dyslipidemia, n (%) | 72 (78.3) | 221 (76.5) | 0.72 |
| GFR, mL/min/1.73 m2, mean (SD) | 81.8 (25.9) | 74.7 (25.9) | 0.025 |
| LVEF, %, median (Q1–Q3) | 50.0 (41.0–60.0) | 53.0 (40.0–60.0) | 0.75 |
| Radial access, n (%) | 78 (84.8) | 235 (81.3) | 0.45 |
Abbreviations: BMI, body mass index; CABG, coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; GFR, glomerular filtration rate; LVEF, left ventricle ejection fraction; MI, myocardial infarct; PAD, peripheral arterial disease; PCI, percutaneous coronary intervention; TIA, transient ischemic attack.